Gf Fund Management Co. Ltd. Mersana Therapeutics, Inc. Call Options Transaction History
Gf Fund Management Co. Ltd.
- $4.62 Trillion
- Q4 2024
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding MRSN
# of Institutions
136Shares Held
101MCall Options Held
77.2KPut Options Held
453K-
Nextech Invest Ag12.1MShares$6.4 Million3.22% of portfolio
-
Eco R1 Capital, LLC San Francisco, CA11.3MShares$6 Million0.76% of portfolio
-
Vr Adviser, LLC New York, NY10.3MShares$5.44 Million2.42% of portfolio
-
Bain Capital Life Sciences Investors, LLC Boston, MA8.66MShares$4.59 Million3.35% of portfolio
-
Black Rock Inc. New York, NY8.38MShares$4.44 Million0.0% of portfolio
About Mersana Therapeutics, Inc.
- Ticker MRSN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 97,169,296
- Market Cap $51.5M
- Description
- Mersana Therapeutics, Inc., a clinical stage biopharmaceutical company, develops antibody drug conjugates (ADC) for cancer patients with unmet need. It develops XMT-1592, a Dolasynthen ADC targeting NaPi2b-expressing tumor cells, which is in phase I clinical trial for the treatment of ovarian cancer and NSCLC adenocarcinoma. The company also dev...